165 236

Cited 26 times in

The Korean guideline for cervical cancer screening

Other Titles
 자궁경부암 검진 권고안 
 Kyung Jin Min  ;  Yoon Jae Lee  ;  Mina Suh  ;  Chong Woo Yoo  ;  Myong Cheol Lim  ;  Jaekyung Choi  ;  Moran Ki  ;  Yong Man Kim  ;  Jae Weon Kim  ;  Jea Hoon Kim0  ;  Eal Whan Park  ;  Hoo Yeon Lee  ;  Sung Chul Lim  ;  Chi Heum Cho  ;  Sung Ran Hong  ;  Ji Yeon Dang  ;  Soo Young Kim  ;  Yeol Kim  ;  Won Chul Lee  ;  Jae Kwan Lee 
 JOURNAL OF GYNECOLOGIC ONCOLOGY, Vol.26(3) : 232-239, 2015 
Journal Title
Issue Date
Adult ; Age Factors ; Aged ; Early Detection of Cancer/adverse effects ; Early Detection of Cancer/methods* ; Early Detection of Cancer/standards ; Evidence-Based Medicine ; False Positive Reactions ; Female ; Humans ; Hysterectomy ; Middle Aged ; Papillomavirus Infections/diagnosis ; Papillomavirus Vaccines ; Patient Selection ; Pregnancy ; Pregnancy Complications, Neoplastic/diagnosis ; Republic of Korea ; Review Literature as Topic ; Uterine Cervical Neoplasms/diagnosis* ; Vaginal Smears/adverse effects ; Vaginal Smears/methods ; Vaginal Smears/standards ; Young Adult
Mass Screening ; Papanicolaou Test ; Uterine Cervical Neoplasms
The incidence rate of cervical cancer in Korea is still higher than in other developed countries, notwithstanding the national mass-screening program. Furthermore, a new method has been introduced in cervical cancer screening. Therefore, the committee for cervical cancer screening in Korea updated the recommendation statement established in 2002. The new version of the guideline was developed by the committee using evidence-based methods. The committee reviewed the evidence for the benefits and harms of the Papanicolaou test, liquid-based cytology, and human papillomavirus (HPV) testing, and reached conclusions after deliberation. The committee recommends screening for cervical cancer with cytology (Papanicolaou test or liquid-based cytology) every three years in women older than 20 years of age (recommendation A). The cervical cytology combined with HPV test is optionally recommended after taking into consideration individual risk or preference (recommendation C). The current evidence for primary HPV screening is insufficient to assess the benefits and harms of cervical cancer screening (recommendation I). Cervical cancer screening can be terminated at the age of 74 years if more than three consecutive negative cytology reports have been confirmed within 10 years (recommendation D).
Files in This Item:
T201503967.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Jae Hoon(김재훈) ORCID logo https://orcid.org/0000-0001-6599-7065
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.